IE
CSBR icon

Israel Englander’s Champions Oncology CSBR Stock Holding History

Israel Englander’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,203
Closed -$70.5K – 5821
2025
Q4 		$70.5K Sell
10,203
-2,432
-19% -$16.2K ﹤0.01% 5684
2025
Q3 		$81.8K Sell
12,635
-11,429
-47% -$80.5K ﹤0.01% 5750
2025
Q2 		$177K Sell
24,064
-42,549
-64% -$300K ﹤0.01% 5400
2025
Q1 		$578K Buy
66,613
+55,672
+509% +$564K ﹤0.01% 4720
2024
Q4 		$93.8K Buy
10,941
+178
+2% +$896 ﹤0.01% 5485
2024
Q3 		$52.4K Buy
+10,763
New +$50.5K ﹤0.01% 5685
2023
Q4 		– Sell
-33,466
Closed -$208K – 6155
2023
Q3 		$208K Sell
33,466
-11,364
-25% -$71.8K ﹤0.01% 5100
2023
Q2 		$282K Sell
44,830
-15,423
-26% -$79.6K ﹤0.01% 4928
2023
Q1 		$242K Buy
60,253
+1,051
+2% +$4.49K ﹤0.01% 5059
2022
Q4 		$267K Buy
59,202
+4,780
+9% +$31.2K ﹤0.01% 5166
2022
Q3 		$408K Buy
54,422
+1,874
+4% +$15.7K ﹤0.01% 5129
2022
Q2 		$425K Sell
52,548
-1,253
-2% -$9.58K ﹤0.01% 5087
2022
Q1 		$437K Sell
53,801
-385
-0.7% -$3.09K ﹤0.01% 5230
2021
Q4 		$433K Sell
54,186
-6,225
-10% -$57.3K ﹤0.01% 5186
2021
Q3 		$617K Sell
60,411
-27,899
-32% -$284K ﹤0.01% 5154
2021
Q2 		$908K Buy
+88,310
New +$895K ﹤0.01% 4752
2019
Q2 		– Sell
-14,869
Closed -$146K – 4100
2019
Q1 		$146K Sell
14,869
-327
-2% -$3.26K ﹤0.01% 3797
2018
Q4 		$119K Sell
15,196
-10,173
-40% -$117K ﹤0.01% 3517
2018
Q3 		$443K Buy
+25,369
New +$226K ﹤0.01% 3303
2018
Q1 		– Sell
-14,164
Closed -$55K – 3702
2017
Q4 		$55K Sell
14,164
-7,853
-36% -$28K ﹤0.01% 3717
2017
Q3 		$81K Buy
+22,017
New +$67.4K ﹤0.01% 3376
2016
Q4 		– Sell
-22,302
Closed -$37K – 3387
2016
Q3 		$37K Buy
+22,302
New +$41.5K ﹤0.01% 3193

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $368M AUM 28.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Israel Englander's CSBR Position: Q1 2026 in Review

Israel Englander sold out of Champions Oncology (CSBR) in Q1 2026, closing a stake of 10,203 shares — an estimated $70.5K sold.

Israel Englander first reported a position in CSBR in Q3 2016 and held it in 22 quarters. The position peaked at $908K in Q2 2021. 25 funds tracked by Wall St. Rank hold CSBR as of Q1 2026.

  • Israel Englander reported no remaining Champions Oncology position as of Q1 2026 after selling out during the quarter.
  • Israel Englander sold 10,203 Champions Oncology shares in Q1 2026, an estimated $70.5K.
  • Israel Englander first reported a position in Champions Oncology in Q3 2016 and held it in 22 quarters.
  • Israel Englander's Champions Oncology position peaked at $908K in Q2 2021.
  • 25 funds tracked by Wall St. Rank held Champions Oncology as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.